Carrera Capital Advisors Gilead Sciences, Inc. Transaction History

Carrera Capital Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	BUY	$89.14 - $117.41 $115,525 - $152,163	1,296 Added 3.88%	34,696 $3.89 Billion
Q4 2024 Feb 06, 2025	BUY	$83.95 - $97.9 $659,343 - $768,906	7,854 Added 30.74%	33,400 $3.09 Billion
Q3 2024 Nov 05, 2024	BUY	$66.59 - $83.99 $325,358 - $410,375	4,886 Added 23.65%	25,546 $2.14 Billion
Q2 2024 Aug 27, 2024	BUY	$63.15 - $72.88 $1.3 Million - $1.51 Million	20,660 New	20,660 $1.42 Billion

2,386

1.01B

8.58M

7.35M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $156B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Carrera Capital Advisors, based on Form 13F filings with the SEC.

Stay updated on Carrera Capital Advisors with notifications on news.